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Modern society demands greater scrutiny of the potential
health risks and benefits of long-term, and sometimes life-
long, exposure to drugs, chemicals, and substances found
in consumer products and the environment. Organizations
such as companies and academic consortia conduct large
multi-year scientific studies that entail the collection and
analysis of thousands of data points. The individual experi-
ments are often conducted over many physical sites and
with internal and outsourced components. To extract
maximum value, the interested parties need to verify the
accuracy and reproducibility of automated collection and
analysis workflows in systems biology before the initiation
of large multi-year studies.
Traditional verification using the peer-review process
has shortcomings, such as lack of scalability, which ren-
ders it insufficient for the assessment of high-throughout
research. A team of researchers at Philip Morris Interna-
tional (PMI) and IBM, whose aim is to improve the effec-
tiveness of scientific studies and the verification of
scientific findings, propose a scheme called IMPROVER,
for Industrial Methodology for Process Verification of
Research. This methodology evaluates a research pro-
gram by dividing its workflow into smaller building
blocks, whereby the verification of each building block
can be done internally or externally via challenge-based
‘crowd-sourcing’ to a research community.
Scientific challenges will be broadcast to potential stake-
holders in the form of an open call for participation, with
the intention of providing the community with the oppor-
tunity to test their computational methods on new data as
well as to partake in a collaborative effort whose ultimate
goal could contribute to solving a grand scientific problem.
Considering cancer as the leading cause of death
worldwide, we formulate the Diagnostics Signature Chal-
lenge to evaluate novel approaches for the identification
of robust and predictive signatures for this disease. The
goal of a Diagnostics Signature Challenge is to verify that
transcriptomics data contain enough information for the
determination and prognosis of certain human disease
states that could profit from better diagnostics signatures.
Here we will describe the approach, the necessary opera-
tional steps, and how we intend to engage the wider
scientific community to assess the applicability of the
IMPROVER approach to molecular diagnostics (that is,
genomic signatures).
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